6. Any approved anti-cancer therapy, including chemotherapy or hormonal therapy, within 3 weeks prior to initiation of study treatment, with the following exceptions: - Hormone-replacement therapy or oral contraceptives - Tyrosine kinase inhibitors (TKIs) that have been discontinued > 7 days prior to Cycle 1, Day 1; screening scans must be obtained after discontinuation of prior TKIs.